Site Search

... making it less punitive for patients and easier for them to weather the financial storm of their illness. ACS CAN, along with the many public health and medical leaders who advocated for the passage of the proposal, see it as an opportunity to minimize the negative, cascading impacts of medical debt. This legislative session, the mother-daughter duo will join fellow patient advocates, medical leaders and public health allies in advancing legislation to improve access to biomarker testing, eliminate financial barriers to prostate cancer screening and end ... affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We stand with our volunteers, working to make cancer a top priority for policymakers in cities, ...

... Trials Day on the 20th, the American Cancer Society Cancer Action Network (ACS CAN) joins cancer survivors and caregivers as well as key public health, patient and provider groups from across New York in calling on state lawmakers to support legislation that can improve access to clinical ... trials. Clinical trials are critical to medical innovation, advancing potential new cancer treatments from the research setting to the cancer care clinic. Increasingly, cancer clinical trials are driven by biomarker testing and the development of targeted therapies. Patients’ biomarker ... that involve biomarkers growing from 15% in 2000 to 55% in 2018.” Senate Bill 1196 / Assembly Bill 1673 would require all state-regulated health plans, including Medicaid, to cover comprehensive biomarker testing in cases where patients can benefit thereby increasing many New ...

... State Lawmakers to work with the American Cancer Society Cancer Action Network (ACS CAN) to support cancer prevention, treatment, and access to care during the 2025 legislative session.   According to the 2025 Cancer Facts and Figures report , cancer incidence have generally declined in ... access to biomarker testing, ACS CAN will also ask lawmakers to support the following evidence-based policies:  Ensuring Access to Quality Care •    Colorectal Cancer: ACS CAN will work to require coverage for colorectal cancer screening for uninsured and underinsured patients. ... fertility is a common regret that may affect survivors’ quality of life. ACS CAN supports legislation that would provide cancer patients with health insurance coverage for fertility preservation consistent with recommended medical guidelines.  Reducing the Toll of Tobacco  •   ...

... coverage is failing to keep pace. Communities of color, patients with lower socioeconomic status, rural communities, and patients receiving care in non-academic medical centers are less likely to receive biomarker testing. ACS CAN is planning to work with the Hawaii State Legislature ... coverage of biomarker testing. This resolution is required for the state auditor to conduct a report and allow bills that include certain health insurance changes to move forward.  Without action to expand equitable access to biomarker testing, existing disparities in cancer outcomes ...